Assessment of the Benefits of Adapted Physical Activity in Pediatric Hemodialysis Patients

NCT ID: NCT07118007

Last Updated: 2025-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2029-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Children, adolescents, and young adults undergoing pediatric hemodialysis often experience functional limitations in daily life. Their level of physical activity is generally lower than that of healthy peers of the same age, due to the lack of sports programs adapted both to their medical conditions and to the constraints of dialysis (notably, having to remain in bed for several hours, several times a week). These limitations affect not only their cardiovascular function but also their quality of life.

Through the implementation of an Adapted Physical Activity (APA) program for dialysis patients, we aim to assess the potential benefits of this approach on muscle strength, functional abilities, cardiovascular health, and quality of life

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient requiring hemodialysis for end-stage renal disease

Patient requiring hemodialysis for end-stage renal disease aged 5 to 20 years

Group Type OTHER

adapted physical activity

Intervention Type OTHER

adapted physical activity for 30 to 45 minutes twice per week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

adapted physical activity

adapted physical activity for 30 to 45 minutes twice per week

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient requiring hemodialysis sessions for end-stage renal disease
* Patient aged between 5 and 20 years
* Patient followed in the pediatric nephrology department at hospital Lyon (HFME : Hôpital Femme Mère Enfant)
* Adult patient or parents/legal guardians informed about the study and having provided written consent for participation
* Patient covered by a social security

Exclusion Criteria

Medical or surgical contraindications to adapted physical activity.

* Persons deprived of liberty by judicial or administrative decision.
* Persons undergoing psychiatric care.
* Persons admitted to a healthcare or social facility for reasons other than research participation.
* Adults under legal protection measures (curators)
* Persons not affiliated with a social security scheme or beneficiaries of a similar system
* Pregnant women.
Minimum Eligible Age

5 Years

Maximum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Melodie MOSCA, MD

Role: CONTACT

04 27 85 67 49 ext. +33

Sacha FLAMMIER

Role: CONTACT

04 72 68 13 49 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL25_0588

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.